Inflammatory dying cells exacerbate inflammatory diseases
by markedly elevating CD47 expression, thereby strategically evading their removal. 

CD47, ‘Don’t eat me signal’

Uncleared Inflammatory Dying Cells:
Worsening Diseases

Regenerative Immunotherapy,
Engineered stem cell-derived

SIRP-NV (SBI-102) 

SBI-102 pioneers regenerative immunotherapy, awakening the innate immune system
to amplify its regenerative potential.

SBI-102 can be the game changer
of the CD47 blockade.

CD47 degradation

High safety

Paracrine effect of stem cells

SBI-102, exhibits high target disease expandability, starting with nichebuster therapies for rare diseases and expanding towards blockbuster treatments for intractable diseases.